Ischemic stroke in a young patient with protein C deficiency and prothrombin gene mutation G20210A

Blood Coagulation and Fibrinolysis

Volumn 9, Issue 8, 1998, Pages 757-760

  Arkel, Y S ^a,b   Ku, D H ^a   Gibson, D ^a   Lam, X ^a  

^a OVERLOOK HOSPITAL   (United States)

^b Blood Disorder Ctr Hemostas Throm   (United States)

Author keywords

Protein C deficiency; Prothrombin gene mutation 20210A; Stroke

Indexed keywords

PROTEIN C; PROTHROMBIN;

ADULT; ARTICLE; BRAIN ISCHEMIA; CASE REPORT; FAMILY HISTORY; GENE MUTATION; HUMAN; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; RISK FACTOR; STROKE; THROMBOEMBOLISM;

EID: 0032464898     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199811000-00006     Document Type: Article

References (24)

1. Kohler J, Kasper J, Witt I, Von Reuthern G. Ischemic stroke due to protein C deficiency. Stroke 1990; 21: 1077-1080.
2. Grewal R, Goldberg M. Stroke in protein C deficiency. Am J Med 1990; 89: 5380-5389.
3. Koh S, Chen L. Protein C and S deficiency in children with ischemic cerebrovascular accident. Pediat Neurol 1997; 17: 319-321.
4. Gould RJ, Black K, Pavlakis SG. Neonatal cerebral arterial thrombosis: protein C deficiency. J Child Neurol 1996; 11: 250-251.
5. Kennedy CR, Warner G, Kai M, Chisholm M. Protein C deficiency and stroke in early life. Devel Med Child Neurol 1995; 37: 723-730.
6. Kato H, Shirahama M, Ohmori K, Sunaga T. Cerebral infarction in a young adult associated with protein C deficiency. Angiology 1995; 46: 169-173.
7. Brown DC, Livingston JH, Minns RA, Eden OB. Protein C and protein S deficiency causing childhood stroke. Scottish Med J 1993; 38: 114-115.
8. Gordon BG, Saving KL, McCallister JA, Warkentin PI, McConnel JR, Roberts WM, et al. Cerebral infarction associated with protein C deficiency following allogeneic bone marrow transplantation. Bone Marrow Trans 1991; 8: 323-325.
9. Tsuda M, Miyazaki M, Takada T, Uda Y, Kuzuhara S. A case of protein C deficiency associated with cerebral infarction and obstruction of the deep leg and inferior mesenteric veins. Jpn J Psych Neurol 1993; 47: 887-892.
10. Ridley PD, Ledingham SJM, Lennox SC, Burman JF, Chung HI, Sheffield EA, et al. Protein C deficiency associated with massive cerebral thrombosis following open heart surgery. J Cardiol Surg 1990; 32: 249-251.
11. DeStefano V, Leone G, Teofili L, Ferrelli R, Pollari G, Antonini V, Bizzi B. Transient ischemic attack in a patient with congential protein C deficiency during treatment with stanzolol. Am J Haematol 1988; 29: 120-121.
12. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
13. Hillarp A, Zoller B, Svenssen PJ, Dahlback B. The 20210A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep vein thrombosis. Thromb Haemost 1997; 78: 990-992.
14. Cumming AM, Keeney S, Salden A, Bhavnani M, Shwe KH, Hay CRM. The prothrombin gene G20210A variant: prevalence in a UK anticoagulant clinic population. Br J Haematol 1997; 98: 353-355.
15. Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth Jr WT, et al. A common prothrombin variant (20210 G to A) increase the risk of myocardial infarction in young women. Blood 1997; 90: 1747-1750.
16. Doggen CJM, Visser T, Bertina RM, Manger Cats V, Rosendaal FR. Prothrombin 20210G→A as a moderate risk factor for MI [abstract]. Thromb Haemost 1997; 77 (suppl): 379-379.
17. DeStefano V, Chiusolo P, Paciaroni K, Casorelli I, Rossi E, Molinari M, et al. Prothrombin G20210A mutant genotype is a risk factor for cerebraovascular ischemic disease in young patients. Blood 1998; 91: 3562-3565.
18. Arkel YS, Ku DH, Kamiyama M, Pajaro R, Alder H, Marchand A. Factor V assay as a functional test for the factor V Leiden/resistance to activated protein C syndrome [abstract]. Blood 1995; 86 (suppl): 202a.
19. Arkel YS, Ku DH, Kamiyama M, Pajaro R, Alder H, Marchand A. A highly specific functional test for factor V Leiden; a modified tissue factor assay for activated protein C resistance. Haemostasis 1997; 27: 290-304.
20. Kirschbaum NE, Foster PA. The polymerase chain reaction with sequence specific primers for the detection of the factor V mutation associated with activated protein C resistance. Thromb Haemost 1995; 74: 874-878.
21. Haire W, Newland J. Protein C deficiency and anticardiolipin antibodies in a family with premature stroke. Am J Hematol 1990; 33: 61-63.
22. Devilat M, Toso M, Morales M. Childhood stroke associated with protein C or S deficiency and primary antiphospholipid syndrome. Ped Neurology 1993; 9: 67-70.
23. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. Mechanisms of disease. N Engl J Med 1998; 338: 1042-1050.
24. Ginsburg KS, Liang MH, Newcomer I, Goldhaber SZ, Schur PH, Hennekens CH, et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992; 117: 997-1002.